Daily Activity
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance. (NCT01909557) | University of Catania | 2010-01-01 |
Track Daily Activity automatically
Every clearance here is in the API, with alerts when new ones post.